26
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series

ORCID Icon, , &
Received 18 Oct 2023, Accepted 27 Apr 2024, Published online: 07 May 2024

References

  • Batra S. Spitzoid melanoma of childhood: a case series and review. Melanoma Manag. 2015;2(2):121–125. doi:10.2217/mmt.15.6.
  • Ryan AL, Burns C, Gupta AK, et al. Malignant melanoma in children and adolescents treated in pediatric oncology centers: an Australian and New Zealand children’s oncology group (ANZCHOG) study. Front Oncol. 2021;11:660172. doi:10.3389/fonc.2021.660172.
  • Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C. A meta-analysis of nevus-associated melanoma: Prevalence and practical implications. Journal of the American Academy of Dermatology. 2017;(77)(5):938–945.e4. doi:10.1016/j.jaad.2017.06.149.
  • Hawryluk EB, Moustafa D, Bartenstein D, et al. A retrospective multicenter study of fatal pediatric melanoma. J Am Acad Dermatol. 2020;83(5):1274–1281. doi:10.1016/j.jaad.2020.06.1010.
  • El Sharouni MA, Rawson RV, Potter AJ, et al. Melanomas in children and adolescents: Clinicopathologic features and survival outcomes. J Am Acad Dermatol. 2023;88(3):609–616. doi:10.1016/j.jaad.2022.08.067.
  • Bartenstein DW, Kelleher CM, Friedmann AM, et al. Contrasting features of childhood and adolescent melanomas. Pediatr Dermatol. 2018;35(3):354–360. doi:10.1111/pde.13454.
  • Raghavan SS, Peternel S, Mully TW, et al. Spitz melanoma is a distinct subset of spitzoid melanoma. Mod Pathol. 2020;33(6):1122–1134. doi:10.1038/s41379-019-0445-z.
  • Moore-Olufemi S, Herzog C, Warneke C, et al. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg. 2011;253(6):1211–1215. doi:10.1097/SLA.0b013e318217e852.
  • Pol-Rodriquez M, Lee S, Silvers DN, Celebi JT. Influence of age on survival in childhood spitzoid melanomas. American Cancer Society. 2007;109(8):1579–1583. doi:10.1002/cncr.22584.
  • Davis KL, Fox E, Merchant MS, et al. Nivolumab in children and young adults with relapsed or refractory solid tumors or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020;21(4):541–550. doi:10.1016/S1470-2045(20)30023-1.
  • Richards MK, Czechowicz J, Goldin AB, et al. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma. JAMA Otolaryngol Head Neck Surg. 2017;143(1):34–40. doi:10.1001/jamaoto.2016.2630.
  • Pappo AS, McPherson V, Pan H, et al. A prospective, comprehensive registry that integrates the molecular analysis of pediatric and adolescent melanocytic lesions. Cancer. 3825;127(20):3825–3831. doi:10.1002/cncr.33750.
  • Cordoro KM, Gupta D, Frieden IJ, McCalmont T, Kashani-Sabet M. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children. J Am Acad Dermatol. 2013;68(6):913–925. doi:10.1016/j.jaad.2012.12.953.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.